Heal, D J <br/><br/>
A review of late-stage CNS drug candidates for the treatment of obesity.  [electronic resource] 

 -  International journal of obesity (2005)  Jan 2013 
 - 107-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1476-5497 
<br/><br/><label>Standard No.: </label>10.1038/ijo.2012.26  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Obesity Agents--administration & dosage<br/>Bupropion--pharmacology<br/>Central Nervous System Stimulants--pharmacology<br/>Drug Administration Schedule<br/>Drug Approval<br/>Drug Combinations<br/>Drug Design<br/>Drugs, Investigational<br/>Female<br/>Guidelines as Topic<br/>Humans<br/>Male<br/>Naltrexone--pharmacology<br/>Obesity--drug therapy<br/>Patient Selection<br/>Phentermine--pharmacology<br/>Receptor, Serotonin, 5-HT2C--drug effects<br/>Risk Factors<br/>Risk Reduction Behavior<br/>United Kingdom--epidemiology